User:Ann Taylor/GLP-1 agonists: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
← Older editNewer edit →
Ann Taylor (talk | contribs)
997 edits
No edit summary
Ann Taylor (talk | contribs)
997 edits
No edit summary
Line 1: Line 1:
==GLP-1 agonists==
==GLP-1 agonists==
<StructureSection load='7KI0' size='340' side='right' caption='Caption for this structure' scene='GLP-1 bound to receptor complex'>
<StructureSection load='7KI0' size='340' side='right' caption='GLP-1 bound to receptor complex'>


<scene name='10/1043704/Glp-1_peptide/1'>Glucagon-like peptide agonists</scene> (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. They GLP-1 agonists bind to the GLP receptor.
<scene name='10/1043704/Glp-1_peptide/1'>Glucagon-like peptide agonists</scene> (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. They GLP-1 agonists bind to the GLP receptor.

Revision as of 23:14, 5 December 2024

GLP-1 agonistsGLP-1 agonists


(GLP) are used to treat type 2 diabetes and obesity [1]. They GLP-1 agonists bind to the GLP receptor.

The GLP receptor is a G-protein coupled receptor. Its secondary structure is highlighted in . The hydrophobic residues are shown in grey and the polar residues are shown in magenta in .


GLP-1 bound to receptor complex

Drag the structure with the mouse to rotate

ReferencesReferences

  1. ↑ Drake T, Landsteiner A, Langsetmo L, MacDonald R, Anthony M, Kalinowski C, Ullman K, Billington CJ, Kaka A, Sultan S, Wilt TJ. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med. 2024 Apr 19. PMID:38639549 doi:10.7326/M23-1490
Retrieved from "https://proteopedia.openfox.io/wiki/index.php?title=User:Ann_Taylor/GLP-1_agonists&oldid=4250822"